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ABSTRACT: Assessing the physical stability of proteins is one of the most
important challenges in the development, manufacture, and formulation of
biotherapeutics. Here, we describe a method for combining and automating
circular dichroism and intrinsic protein ﬂuorescence spectroscopy. By
robotically injecting samples from a 96-well plate into an optically compliant
capillary ﬂow cell, complementary information about the secondary and
tertiary structural state of a protein can be collected in an unattended
manner from considerably reduced volumes of sample compared to
conventional techniques. We demonstrate the accuracy and reproducibility
of this method. Furthermore, we show how structural screening can be used
to monitor unfolding of proteins in two case studies using (i) a chaotropic
denaturant (urea) and (ii) low-pH buﬀers used for monoclonal antibody
(mAb) puriﬁcation during Protein A chromatography.
The majority of biologics are recombinant proteinsproduced by engineered microbial, plant, or animal
cells, and processes for their manufacture rely on harmonious
integration of a complex series of upstream and downstream
operations.1 The stringent requirements for proving that
biotherapeutic protein products are correctly folded into the
active three-dimensional (3D) structure is a vital concern of
the biopharma industry. Proteins, especially large complex
human proteins, exhibit a propensity to unfold and aggregate
in response to often quite small changes in the process
environment.2,3 Loss of structural integrity is a recognized
factor in reducing a drug’s therapeutic eﬃcacy and invoking
immune responses in patients.4,5
The considerable number of factors that inﬂuence
biotherapeutic quality attributes has contributed to a series
of risk-based initiatives governing their manufacture.6 These
measures aim to safeguard product consistency, quality, and
purity by ensuring that the manufacturing process remains
substantially the same over time. Important among these is the
Food and Drug Administration’s guidance on Process
Analytical Technology (PAT) within the pharmaceutical
sector.7−9 In the case of biotherapeutic protein targets,
where maintenance of the correct 3D structure is essential
for drug eﬃcacy, improved understanding of the impact of
processing environments relies, in large part, on the develop-
ment of robust high-throughput analytical techniques capable
of eﬀectively monitoring a given protein’s structural state at all
stages during processing and formulation.10
Circular dichroism (CD) and intrinsic ﬂuorescence are
sensitive, nondestructive biophysical techniques employed for
studying changes in the solution-state conformation of
proteins.11,12 CD is a spectroscopic technique that measures
the diﬀerential absorption of left- and right-handed circularly
polarized light. Asymmetric absorption of the peptide back-
bone in the far-UV region provides an excellent means of
measuring changes in the total secondary structure of a
protein, while absorption in the near-UV region arising from
aromatic amino acids provides a good indicator of tertiary
structure changes. Intrinsic protein ﬂuorescence is a comple-
mentary technique that provides information on the state of
protein structure from changes in the local environment of
aromatic amino acid residues.13−17
An existing challenge with using CD and ﬂuorescence
together for routine structural screening is that instruments are
not conﬁgured for use in an industrial setting, where speed and
autonomy are paramount. Conventionally, far-UV CD is
carried out in quartz cuvettes with a path length of 0.1 cm,
requiring ∼200 μL protein samples of 0.1−0.2 mg/mL.11
Unless a CD spectrometer has been speciﬁcally adapted with a
dedicated ﬂuorescence detector, ﬂuorescence spectra are
gathered using a separate instrument in a diﬀerent cuvette.
As both protein sample and buﬀer spectra must be collected
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(ideally in the same cuvette for CD) with cleaning between
measurements, performing spectral analyses on many samples
can be time-consuming. Further, the optical constraints of CD
render the use of traditional plate reader type formats diﬃcult,
motivating past approaches to increase sample throughput
either by increasing the number of cuvettes using a carousel
holder18 or employing a liquid handling robot to load a ﬁxed-
position, square-faced cuvette.19
A diﬀerent approach to increasing sample throughput has
been taken in this work, inspired in part by the pioneering
work of Synovec and Yeung,20,21 and in particular, building on
an earlier study by Waldron et al.22 who introduced an ultralow
volume system for CD comprising an extruded quartz capillary
as the optical cell (replacing the standard quartz cuvette) and
modiﬁed optical conﬁguration. Speciﬁcally, we detail the
systematic development and validation of an automated high-
throughput capillary-based CD/ﬂuorescence (ht-caCD/F)
measurement system and demonstrate its utility as a PAT
tool for bioprocess development work. First, we describe the
components of the measurement system, placing special
emphasis on pairing the optically transparent ﬂow cell with
an optical arrangement that maximizes low-wavelength
performance. Second, we show how sample delivery was
optimized to allow highly eﬃcient transfer of samples as small
as 40 μL containing just 4 μg of protein. Finally, we employ the
ht-caCD/F system as a PAT tool for (i) monitoring
conformational changes of bovine serum albumin (BSA) and
a monoclonal antibody (mAb) under chemical denaturing
conditions and (ii) measuring changes to the structure of the
mAb on exposure to 24 diﬀerent buﬀers spanning pHs of 2.2−
8.05.
■ EXPERIMENTAL SECTION
Materials. The quartz capillary (3.5 mm o.d, 1.20 mm i.d)
and PEEK tubing (1.59 mm o.d., 0.25 mm i.d.) employed for
construction of the ﬂow cell were purchased from Enterprise-Q
(Manchester, Lancs, U.K.) and BGB Analytik Vertrieb GmbH
(Rheinfelden, Germany), respectively. Both the uncoated UV
fused-silica double convex lens (25 mm diameter, 50 mm
eﬀective focal length; cat. no. 48-294) used to focus the light
beam in front of the ﬂow cell and focusing lens mount were
provided by Edmund Optics Ltd. (Nether Poppleton, York,
Yorks, U.K.). Corning 96-well NBS microplates were acquired
from Corning Life Sciences B.V. (Amsterdam, The Nether-
lands), and the bioinert Rheodyne model 9010 six-port
injector was supplied by Merck KgaA (Darmstadt, Germany).
The puriﬁed humanized IgG1 mAb used in this work targets
the HER2 receptor and was provided by Pall Biotech
(Portsmouth, Hants, U.K.) at a stock concentration of 10
mg/mL in 10 mM sodium phosphate pH 7.1 buﬀer. Prior to
sample preparation, 0.3 mL aliquots of stock mAb were
exchanged into water by means of size exclusion chromatog-
raphy using PD MiniTrap G-10 columns (GE Healthcare,
Uppsala, Sweden), and mAb concentration was determined in
a spectrophotometer assuming A279nm
1% = 15.0. Bovine serum
albumin Cohn fraction V (fatty acid free, low endotoxin,
lyophilized powder; A279nm
1% = 6.67) and chemicals, glycine
(≥98.5%), anhydrous sodium acetate (≥99.0%), and (1S)-
(+)-10-camphorsulfonic acid (CSA) ammonium salt, were
obtained from Merck KgaA (Darmstadt, Germany). Glacial
acetic acid (≥99.7%), hydrochloric acid (∼37%), urea
(≥99.5%, Electran molecular biology grade), sodium dihy-
drogen orthophosphate dihydrate (≥99.0%), and anhydrous
disodium hydrogen orthophosphate (≥99.5%) were supplied
by Fisher Scientiﬁc U.K. (Loughborough, Leics, U.K.). Citric
acid monohydrate (≥99.7%) and trisodium citrate dihydrate
(≥99.0%) were acquired from VWR International (Leighton
Buzzard, Beds, U.K.), and Hellmanex II special cleaning
concentrate was from Hellma GmbH & Co. KG (Müllheim,
Germany). All other materials were obtained from Merck
KgaA (Darmstadt, Germany), and all solutions were prepared
using deionized water (resistivity 15.0 MΩ·cm at 22 °C)
puriﬁed by a PURELAB Option-R Ultra water puriﬁcation
system (ELGA LabWater, High Wycombe, U.K.).
Instrument Overview. Figure 1A shows a schematic
representation of the automated sampling system developed
using parts from a high-performance liquid chromatography
(HPLC) system plus an extruded quartz capillary cut from a
length supplied by Enterprise-Q. It comprises a modiﬁed
autosampler (Jasco AS-2055) and HPLC pump (Jasco PU-
1580) conﬁgured to inject protein samples into a quartz
capillary ﬂow cell held in the beam path of a Jasco J-1500 CD
spectrometer (Jasco U.K. Ltd., Great Dunmow, Essex, U.K.)
which is focused down to the 1 mm wide capillary window of
the sample holder. During sample loading, sample is drawn
from a 96-well plate using a three-axis robotic needle, and then
transferred to a holding loop for injection. A mobile phase of
deionized water transfers sample to the capillary, and on
reaching the ﬂow cell, ﬂow is stopped. The CD spectrometer
and ﬂuorescence detector are then electronically triggered to
analyze the sample. Fluorescence spectra are recorded using an
Ocean Optics HR2000+ CCD array detector with a ﬁber-optic
cable attachment (Ocean Optics, Largo, FL, U.S.A.). CD and
absorbance spectra are simultaneously collected thereafter by
the CD spectrometer.
Flow Cell Design. A ﬂow cell was constructed by carefully
tapering the ends of two pieces of PEEK tubing (60 and 2 cm)
with a scalpel to allow their insertion (∼5 mm deep) into
either end of a 3 cm length of quartz capillary (Figure 1B).
Araldite rapid two-part epoxy glue was applied to the joints,
which were then heated over a Bunsen ﬂame to create tight
seals. The long PEEK delivery tube of the ﬂow cell was
attached directly to the column outlet of the autosampler’s six-
way valve (Figure 1A) in order to reduce the volume from
injection valve to capillary down to ∼30 μL, and ﬂexible PTFE
waste tubing was connected to the short PEEK exit tube. A
3D-printed capillary mounting (Figure 1, parts B and C)
designed using AutoCAD software (AutoDesk Inc., San Rafael,
CA, U.S.A.) was employed to securely ﬁx the capillary within
the beam and immediately in front of the instrument’s
photomultiplier tube (Figure 1A). The capillary mounting
features 1 mm wide apertures at the entrance and exit faces of
the capillary (Figure 1, parts B and C) to mask the capillary
edges from incoming light, thereby ensuring that light reaching
the detector has passed through, and not around, the contained
sample. An opening at 90° to the incident beam was made in
the capillary mounting (Figure 1, parts A and C) in order to
accommodate the SMA-905 attachment of the ﬁber-optic cable
for detecting ﬂuorescence, and a 2.5 cm quartz biconvex lens of
5.0 cm focal length was ﬁtted to the sample stage of the
spectrometer to focus light onto the front face of the capillary
and enhance spectral resolution (Figure 1, parts A and C).
Sample Handling. To eliminate potential sample
adsorption within the ﬂow path, the stainless-steel needle,
transfer tube, and holding loop of the autosampler were all
replaced with PEEK tubing. Sample dilution on delivery was
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minimized by adjusting the autosampler’s aspiration settings to
separate the sample from the ﬂanking mobile phase by
sandwiching between two air bubbles (“double” air-segmented
delivery), the sizes of which were adjusted by altering the
volume of air drawn before and after the sample. Further, to
limit potential dilution of analytes by residual mobile ﬂuid on
the ﬂow path walls, the use of an additional air bubble encased
sacriﬁcial wash sample traveling immediately ahead of the bona
ﬁde sample (“triple” air-segmented delivery) was also explored;
schematic illustration is provided in Figure S1. For information
on the settings employed for two and three air bubble
segmented sample delivery, refer to Table S1.
The pump was programmed to load samples at a ﬂow rate of
5.5 μL/s, and the timings were set so that ﬂow stopped
immediately following full sample entry into the capillary
(Table S2). After analysis, samples were ejected from the ﬂow
cell at a ﬂow rate of 16.7 μL/s. The autosampler was
programmed to perform ﬁve consecutive ﬂushes of the needle
and transfer tubing after each injection. To avoid cross-
contamination from sample carryover, a solution of 2% (v/v)
Hellmanex II was loaded after each protein sample. Buﬀer
blank, protein sample, and cleaning agent elements were
arranged in repetitive pattern across a 96-well plate, and the
plate was tightly sealed with plastic wrap to prevent
evaporation of sample during measurement time.
Optical Measurement. The CD spectrometer was used to
collect CD and absorption spectra and provide a source of
excitation light for ﬂuorescence detection. Depending on the
nature of individual experiments, CD data were collected in
time course, step scanning, or continuous scanning modes; the
settings used in each case are given in the accompanying ﬁgure
legends. Fluorescence excitation was carried out with a
wavelength of 290 nm, bandwidth of 9 nm, and digital
integration time (DIT) of 3 s (unless otherwise stated), and
emission spectra were collected at 90° with a 25 cm length of 1
mm core diameter ﬁber-optic cable to take the light to the
detector. The path length of the capillary ﬂow cell (1.18 mm)
was determined by comparing the amplitude of the high-
wavelength 292 nm peak of a 1 mg/mL solution of CSA in
deionized water with that obtained using the 1 mm standard
cuvette.
Automation. The HPLC pump, CD spectrometer, and
ﬂuorescence detector were electronically interfaced in order to
synchronize scanning routines with sample injection (Figure
S2). Two event channels were assigned within the HPLC
pump proﬁle to provide separate triggering control for the CD
and ﬂuorescence spectrometers. A Raspberry Pi model B+
(Raspberry Pi Foundation, Cambridge, Cambs, U.K.) was used
as a central hub to receive event channel signals from the
HPLC pump and initiate spectrometers. A potential diﬀerence
of 3.3 V was applied to the two-event channel termini of the
HPLC pump, so events could be detected via two pull-down
input general-purpose input/output (GPIO) pins on the
Raspberry Pi. A program written in Python version 3.5.0
(https://www.python.org/downloads/release/python-350/)
was used to process incoming event channel signals and relay
them to external trigger pins of the spectrometers via output
GPIO pins (Table S3).
The CCD array ﬂuorescence detector was grounded via pin
5 of its input/output terminal, and the device was triggered to
record multiple spectra by applying a 3.3 V pulse to pin 10,
which could be programmed to last the desired integration
time within the program running on the Raspberry Pi (Table
S3). Fluorescence spectra were recorded and saved during the
signaling interval using the “software input” mode of the
accompanying Ocean Optics SpectraSuite software.
Triggering of the CD spectrometer was controlled via a relay
switch circuit, comprising an NPN transistor (S8050) and relay
switch (SRD-05VDC-SL-C) (SunFounder starter kit V2.0 for
Arduino). A 3.3 V output signal from a Raspberry Pi GPIO to
the transistor base terminus was used to close the circuit
between positive and negative trigger pins of the CD
spectrometer and initiate the macro sequence. Macro
commands for the initiation of CD and ﬂuorescence scanning
routines (Table S2) were written in Jasco Spectra Manager II.
Figure 1. (A) Schematic diagram of the automated circular dichroism
and ﬂuorescence system. The autosampler retrieves sample from a 96-
well plate, and sample is injected to the ﬂow cell. Sample injection is
controlled by a pump proﬁle programmed on the HPLC pump. (B)
Front view of ﬂow cell with dimensions. (C) Annotated isometric
view of the ﬂow cell and focusing lens.
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Upon the CD spectrometer receiving an external signal, macro
commands open the beam shutter to expose the sample to
excitation light for ﬂuorescence, and an event signal is sent to
the CCD array detector to trigger the collection of
ﬂuorescence spectra. Once ﬂuorescence spectra have been
collected, the shutter is closed, and the monochromator then
resets to carry out CD scanning routines. Macro commands
were enclosed in a loop function to allow the reiteration of this
program with the loading of each new sample. A program
written in Python 3.5.0 was used to accumulate and average
ﬂuorescence.txt ﬁles following data collection (Table S3).
■ RESULTS AND DISCUSSION
Design and Calibration of the Flow Cell. In contrast to
conventional ﬂat-walled CD sample chambers, the use of
curved walls of the capillary might be expected to convey some
optical distortion. To test the capillary-based CD/ﬂuorescence
(ht-caCD/F) measurement system (Figure 1) for its suitability
in automated bioprocess development work, calibration data
were collected from samples of 1 mg/mL CSA (Figure 2A)
and 0.1 mg/mL BSA (Figure 2B). CD spectra were recorded
using the capillary ﬂow cell “with” and “without” the focusing
lens, and optical quality was compared to spectra collected in a
standard 1 mm path length quartz cuvette. For ease of
comparison, the 1 mm cuvette ellipticity data were scaled to a
1.18 mm path length (i.e., multiplied by 1.18).
The data show that CD spectra from the capillary closely
approached the quality achieved with a standard cuvette
(Figure 2). The acquired spectra highlight the important role
of the focusing lens in signiﬁcantly improving light ﬂux through
the sample chamber [represented by a lower high-tension
(HT) voltage; Figure 2, parts C and D], thereby reducing
spectral noise across the entire wavelength range (185−270
nm). The two-point CSA calibration ratios23 were −2.00 for
the “capillary ﬂow cell + lens” setup; cf. −2.03 for the cuvette
(Figure 2A). Small deviations (more noticeable for BSA;
Figure 2B) only become apparent below 200 nm due to
increased HT voltage (i.e., lower photon ﬂux) at lower
wavelengths.
Secondary structure deconvolution performed on the
derived BSA spectra using SELCON324 and CDSSTR25
algorithms (reference data set 4, 240−190 nm) gave very
similar average α-helix contents of 63 ± 3% for the cuvette cf.
60 ± 4% for the “capillary + lens” arrangement, demonstrating
that the use of a capillary sample chamber had no signiﬁcant
impact on structural interpretation.
Sample delivery was optimized in experiments employing
BSA injected independently at three diﬀerent concentrations
(0.1, 0.3, and 0.5 mg/mL in 10 mM sodium phosphate buﬀer,
pH 7.4) through the ﬂow cell at a ﬂow rate of 5.5 μL/s,
without stopping ﬂow (Figure 3). The CD spectrometer was
set to record at a wavelength of 222 nm, at which BSA displays
a strongly negative elliptical signal. Resulting “CD222nm vs time”
Figure 2. Optical comparisons of a quartz capillary ﬂow cell (with and
without focusing lens) and a standard quartz cuvette conducted using
(A) 1 mg/mL CSA and (B) 0.1 mg/mL BSA. Spectra were measured
in step scan mode (bandwidth = 1 nm, and DIT = 1 s). Individual CD
spectra and HT voltage traces from six consecutive scans were
averaged. Spectral “noise” plots (standard deviation in CD, σ vs
wavelength) corresponding to the averaged CD spectra in panels A
and B are shown in panels C and D, respectively. The standard
cuvette data were multiplied by 1.18 for direct comparison with the
capillary data. Key: cuvette (blue lines); capillary (red lines); capillary
with focusing lens (green lines); CD spectra and spectral noise (solid
lines); HT (dashed lines).
Figure 3. Comparison of direct and air-segmented sample delivery to
the capillary ﬂow cell. “CD222nm vs time” ﬂow proﬁles arising from
delivery of 40 μL of 0.1, 0.3, and 0.5 mg/mL BSA to the ﬂow cell at a
ﬂow rate of 5.5 μL/s by (A) direct injection into the carrying stream,
(B) double air (20 μL ﬁrst leading air/40 μL sample/20 μL trailing
air), and (C) triple air (20 μL ﬁrst leading air/20 μL sacriﬁcial wash
sample/20 μL second leading air/40 μL sample/20 μL trailing air)
segmented injection. Measurements were made in time course
measurement mode (bandwidth = 2 nm; measurement interval =
0.5 s; DIT = 0.5 s). Three injections of each sample were performed,
and averaged proﬁles are shown. (D) “Maximum CD222nm vs BSA
loading concentration” and (E) “transfer eﬃciency vs sample volume”
(0.1 mg/mL BSA was used) for direct (dash-dotted line), double air-
segmented (dotted line), and triple air-segmented (dashed line)
sample injections into the capillary ﬂow cell and normalized static
measurement in the standard cuvette (solid line). The error bars in
panels D and E derive from three repeated injections at each
concentration.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.9b03259
Anal. Chem. XXXX, XXX, XXX−XXX
D
proﬁles for three diﬀerent sample injection modes are shown in
Figure 3A−C. The maximum CD222nm values derived from
these are plotted against the BSA loading concentration
(Figure 3D), and the impact of sample volume on transfer
eﬃciency is also shown (Figure 3E).
Direct injection of 40 μL samples into the mobile carrier
phase (Figure 3A) resulted in nearly 5-fold dilution (Figure
3D) due to zone broadening upon transfer to the ﬂow cell. To
limit sample diﬀusion in the carrying ﬂuid, the sample
aspiration settings of the autosampler were modiﬁed to
introduce discrete volumes of air either side of the sample,
i.e., one immediately in front, the other immediately behind.
The bubbles of air appear in the ﬂow proﬁles (Figure 3, parts B
and C) as concentration-independent positive ellipticity signals
on either side of the protein sample, arising as a result of
distortion to the path of light passing through an air-ﬁlled
capillary.
The eﬀectiveness of air bubble segmented sample injection
in eradicating the gross sample dilution by the mobile phase cf.
direct injection (Figure 3A) is demonstrated in Figure 3B−E.
The delivery of a 40 μL sample sandwiched between two 20
μL air bubbles, i.e., “double air” segmented injection (Figure
3B), increased the “carried sample” concentration 4-fold to
87.3 ± 0.6% of the theoretical maximum ellipticity, i.e.,
assuming no dilution of sample (Figure 3D). Variation in
segmenting air bubble size between 5 and 30 μL revealed some
sample bleed with the smallest bubbles tested (5 μL), but the
carrying concentration of sample protein (measured as
CD222nm) appeared independent of bubble volume over the
examined range (Figure S3).
The eﬃciency of sample carriage could be improved yet
further (Figure 3C) to 98.6 ± 0.8% of the theoretical εmax
(Figure 3D) by introducing an air bubble segmented
“sacriﬁcial sample” (20 μL) immediately ahead of the
“measured” sample (40 μL). This sacriﬁcial sample served to
“buﬀer” the impact of dilution on the main analyte caused by
residual mobile phase in the ﬂow path or capillary. An
important advantage of this “triple” air-segmented sample
delivery is that it permits delivery of much smaller sample
volumes at high transfer eﬃciency (Figure 3E). For example,
20 and 40 μL samples of 0.1 mg/mL BSA can be delivered at
eﬃciencies of 97.5 ± 2.7% and 98.6 ± 0.8%, respectively, cf.
70.7% and 87.3% for double air-segmented and just 9.9% and
21.9% for direct injection modes. In each instance, the
independent delivery of protein to the ﬂow cell showed highly
reproducible ﬂow proﬁles and concentrations.
Collection of full CD and ﬂuorescence spectra using
automated triple air-segmented sample delivery was sub-
sequently evaluated by loading varying concentrations of BSA
and mAb in the ht-caCD/F system and pausing ﬂow for
scanning routines. Speciﬁcally, this entailed preparing multiwell
plates containing repeated sequences of buﬀer blank, protein
sample, and 2% (v/v) Hellmanex cleaning solution and
automatically collecting CD and ﬂuorescence spectra from
40 μL samples loaded independently three times. Parts A, C,
Figure 4. CD (A and B), UV absorption (C and D), and ﬂuorescence
(E and F) spectra of BSA (left) and mAb (right) acquired with the ht-
caCD/F system. Triple air-segmented delivery was employed to inject
40 μL samples of BSA (in 10 mM sodium phosphate, pH 7.4) and
mAb (in 10 mM sodium phosphate and 154 mM NaF, pH 7.1)
loaded at concentrations of 0.05−0.25 mg/mL. Each sample was
loaded three times at a ﬂow rate of 5.5 μL/s, and the averaged spectra
are shown. CD spectra (A and B) were collected in continuous scan
mode with the following parameters: bandwidth = 2 nm; scan speed =
100 nm/min; DIT = 1 s; averaging over ﬁve scans per sample.
Fluorescence spectra (E and F) were averaged over 14 accumulated
scans per sample (DIT = 3 s).
Figure 5. Case study 1a: using ht-caCD/F to interrogate protein
unfolding. BSA (2.25 mg/mL) in 10 mM sodium phosphate pH 7.4
was diluted 9-fold with varying amounts of urea (in the same buﬀer)
and mixed (1 h, room temperature) to give samples with ﬁnal BSA
and urea concentrations of 0.25 mg/mL and 0−8 M, respectively.
Triple air-segmented delivery was employed to inject 40 μL samples.
Each sample was loaded twice, and obtained spectra were averaged.
(A) CD spectra were collected in continuous scan mode with the
following parameters: bandwidth = 2 nm; scan speed = 100 nm/min;
DIT = 1 s; averaging over ﬁve accumulated scans per sample. (B)
CD222nm vs urea concentration. (C) Fluorescence spectra were
averaged over 14 accumulated scans per sample (DIT = 3 s). (D) λmax
(solid line) and normalized ﬂuorescence intensity (dotted line) vs
urea concentration. The error bars correspond to the standard
deviation of two independent measurements.
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and E of Figure 4 show the CD, absorption, and ﬂuorescence
spectra obtained for ﬁve diﬀerent concentrations of BSA
(0.05−0.25 mg/mL) in 10 mM sodium phosphate buﬀer, pH
7.4, averaged across three independent repeat injections. The
CD spectra (Figure 4A) display the characteristic shape
expected for BSA (RCSB PDB ID 3V03), an α-helical protein
with intense negative maxima at 222 and 208 nm arising from
the n−π* and parallel π−π* transitions, respectively, and a
positive maximum at 192 nm assigned to the perpendicular
π−π* transition.26
The ﬂuorescence emission spectra are characterized by a
single peak, maximal at 344 nm (Figure 4B), arising from the
contributions of two tryptophan residues, one (Trp-135)
located in the second α-helix of domain IB in a solvent-
exposed hydrophobic pocket close to the protein surface (λmax
= 348 nm), the other (Trp-214) buried deep in BSA’s interior
within the hydrophobic pocket of domain IIA (λmax = 332 nm)
participating in a hydrophobic packing interaction at the IIA−
IIIA interface.27−31
CD spectra of mAb (Figure 4D) have the character of an
antiparallel β-sheet-rich immunoglobulin, with a positive
maximum at 202 nm assigned to the π−π* transition, a
negative maximum at 217 nm from the n−π* transition, and a
distinctive broad shoulder near 230 nm that has previously
been ascribed to contributions from aromatic side chains.32,33
The intrinsic ﬂuorescence spectra (Figure 4F) have a λmax at
338 nm, resulting from the predominant contribution of
tryptophan. The corresponding absorbance spectra of BSA and
mAb (Figure 4, parts B and E) are both typical of absorption
from the peptide backbone, with a peak at 190 nm and
shoulder at 220 nm.
With the ht-caCD/F system’s strong optical performance
and consistent automated sample delivery conﬁrmed, we next
explored the ht-caCD/F systems potential as a PAT tool in
bioprocess development in two industrially relevant case
studies, namely, (i) monitoring the unfolding of BSA (a well-
characterized and frequently employed model protein) and a
therapeutic mAb under increasing concentrations of the
chaotropic agent urea and (ii) testing the stability of a
therapeutic mAb across a range of pH used in downstream
puriﬁcation.
Case Study 1: Denaturation by Urea. Chaotropic agents
such as urea or guanidine hydrochloride are frequently used to
probe the unfolding events of biological molecules and are
widely employed in industrial bioprocessing settings, e.g., for
the resolubilization of inclusion bodies or as stabilizing
additives in elution buﬀers.34,35 Here, we employed the
automated ht-caCD/F system to interrogate structural changes
induced in BSA and mAb following 1 h of exposure to various
concentrations (0−8 M) of urea.
The addition of low concentrations of urea (1 and 2 M) to
BSA resulted in no observable change to its CD spectrum
(Figure 5A). With increasing urea concentration beyond 3 M,
however, signiﬁcant loss in α-helical content occurred; the far-
UV CD spectrum (Figure 5, parts A and B) became
progressively less negative, and the magnitude of the 222 nm
maximum diminished in roughly linear fashion with increase in
urea concentration between 2 and 7 M (Figure 5B). At the
highest urea concentration employed (8 M), the 222 nm
maximum observed in the native BSA spectrum was no longer
visible, but the negative shoulder between 215 and 230 nm
implies that BSA, though denatured, is not completely
unfolded, i.e., it exists in a denatured constrained state devoid
of long-range order.36−38
The ﬂuorescence emission spectra corresponding to the
Figure 5A CD data show urea concentration-dependent
quenching of tryptophan ﬂuorescence (Figure 5C), with little
quenching observed at lower concentrations and strong
quenching above 3 M urea, with normalized ﬂuorescence
intensity falling to ca. 50% at 7 M urea (Figure 5D). The
ﬂuorescence wavelength maximum, λmax (Figure 5D), under-
goes gradual blue (hypsochromic) shifting over the 0−5 M
urea concentration range (falling from 344.8 to 340.6 nm)
followed by strong red (bathochromic) shifting between 5 and
8 M urea (λmax reaching 349.1 nm). These results are in strong
agreement with urea-dependent hypsochromic and bath-
ochromic shifts in BSA’s ﬂuorescence emission spectrum
reported previously,30 and likely reﬂect a two-stage rearrange-
ment of the protein’s packing structure. In the ﬁrst stage, we
envisage limited unfolding by low concentrations of the
chaotrope (1−5 M urea) creates a more hydrophobic
environment around Trp-214, resulting in the observed
hypsochromic shift, and in the second, high chaotrope
concentrations (6−8 M urea) induce extensive unfolding and
exposure of tryptophan residues to a polar solvent environ-
ment, and a concomitant bathochromic shift.
The unfolding of mAb in urea diﬀered markedly from that
exhibited by BSA. With increasing urea concentration the mAb
showed little conformational change until 6 M urea (Figure 6).
The CD spectra showed most variance at low wavelengths,
Figure 6. Case study 1b: using ht-caCD/F to interrogate protein
unfolding. mAb (1.80 mg/mL) in 10 mM sodium phosphate pH 7.1
was diluted 9-fold with varying amounts of urea (in the same buﬀer)
and mixed (1 h, room temperature) to give samples with ﬁnal mAb
and urea concentrations of 0.20 mg/mL and 0−8 M, respectively.
Triple air-segmented delivery was employed to inject 40 μL samples.
Each sample was loaded twice, and obtained spectra were averaged.
(A) CD spectra were collected in continuous scan mode with the
following parameters: bandwidth = 2 nm; scan speed = 100 nm/min;
DIT = 1 s; averaging over ﬁve accumulated scans per sample. (B)
Fluorescence spectra were averaged over 14 accumulated scans per
sample (DIT = 3 s). (C) CD222nm vs urea concentration. (D) λmax
(solid line) and normalized ﬂuorescence intensity (dotted line) vs
urea concentration. The error bars correspond to the standard
deviation of two independent measurements.
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which were largely obscured by the cutoﬀ limit arising from
urea absorbance at ∼210 nm (Figure 6, parts A and B). Loss of
β-sheet structure was reported at 213 nm in the presence of ≥6
M urea, and at 8 M a small change at 238 nm was also
observed. A considerable bathochromic shift of the ﬂuo-
rescence signal at 7−8 M urea indicates extensive unfolding of
protein structure at high chaotrope concentrations, reaching
346.3 nm at 8 M cf. 337.6 in native state (Figure 6D). This red
shift coincided with a dramatic increase in ﬂuorescence
intensity (reaching twice the native emission at 8 M urea).
Unlike BSA, the intrinsic ﬂuorescence emission of the native
state was more quenched than in the denatured state, which is
typical of immunoglobulin domains due to the close proximity
of tryptophan residues to disulﬁde bonds in the folded
conformation.39,40
Case Study 2: mAb Stability Testing. Protein A
chromatography is the most widely used initial capture step
in antibody puriﬁcation in industry. The high aﬃnity of
Protein A for the Fc region of immunoglobulin facilitates >95%
puriﬁcation in a single processing step. However, low-pH
elution buﬀers are required to break the protein’s interaction
with resin, often ranging from pH 2.5 to 4.41,42 Furthermore, in
pharmaceutical operations, mAbs are incubated following
elution at low pH for long periods of time for viral
inactivation.5 The acidic conditions used in mAb downstream
processing are often considered to contribute to the
deterioration in product integrity.43 In particular, Protein A
chromatography is frequently associated with increased
inactivation rates due to aggregation.35,44 Thus, it is important
to understand the acid tolerance of mAb products on a case-
by-case basis.
This work has employed automated ht-caCD/F to inter-
rogate the structural transitions of mAb (0.20 mg/mL ﬁnal
concentration) formulated in buﬀers commonly employed
during the various stages (loading, washing, elution, viral hold)
of Protein A aﬃnity chromatography (Figure 7). Twenty-four
diﬀerent buﬀers spanning the pH range of 2.2−8.05 were
tested (i.e., sodium phosphate, pH 5.85−8.05; sodium acetate,
pH 3.9−5.5; sodium citrate, pH 3.1−6.15; glycine−hydro-
chloric acid, pH 2.2−3.4), and these were employed at 20 mM
so as to maintain low background absorption in the far-UV
region.
At near-neutral pH values (encountered during loading and
washing phases) the CD (Figure 7A) and ﬂuorescence (Figure
7B) spectra (Figure 7I−K) indicate little variation in mAb
structure between pH 8 and 6. With further reduction in pH
from 6 to 3, a slight gradual drop in ellipticity at 203 nm from
∼10 to 8.5 mdeg (Figure 7I) is paralleled by a 1 nm red shift in
Figure 7. Case study 2: monoclonal antibody stability testing. Twenty-four diﬀerent buﬀers spanning the pH range of 2.2−8.05 were tested with
mAb at a ﬁnal concentration of 0.20 mg/mL, i.e., 20 mM sodium phosphate (pH 8.05, 7.65, 7.10, 6.60, 6.20, and 5.85), sodium acetate (pH 5.50,
5.05, 4.60, 4.25, and 3.90), sodium citrate (pH 6.15, 5.75, 5.35, 5.00, 4.65, 4.30, 4.00, 3.60, and 3.10), and glycine−hydrochloric acid (pH 3.40,
3.00, 2.60, and 2.20). Triple air-segmented delivery was employed to inject 40 μL samples. Each sample was loaded twice, and the obtained spectra
were averaged. (A−D) CD spectra were collected in continuous scan mode with the following parameters: bandwidth = 2 nm; scan speed = 100
nm/min; DIT = 1s; averaging over four accumulated scans per sample. (E−H) Fluorescence spectra were averaged over ﬁve accumulated scans per
sample (DIT = 4 s). (I) CD203nm vs pH. (J) λmax vs pH. (K) Normalized ﬂuorescence intensity vs pH. Error bars correspond to the standard
deviation of two independent measurements.
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λmax (from 337 to 338 nm; Figure 7J) and marked drop
(>20%; Figure 7K) in ﬂuorescence intensity. The stronger
ﬂuorescence quenching of aromatic residues within the mAb
by citrate cf. acetate (Figure 7, parts F, G, and K) is likely due
to preferential accumulation of quenching citrate ions near the
mAb’s surface.43−46
More signiﬁcant perturbations to mAb structure are
observed as the pH is reduced yet further from ∼3 to 2.2,
with CD revealing severe loss of β sheet structure (CD203nm
falling from >8 mdeg to <0.5 mdeg; Figure 7, parts D and I)
and ﬂuorescence spectra showing strong red shifting of λmax
(from 338 to 342 nm; Figure 7, parts H and J), but no further
quenching (Figure 7, parts H and K). The spectral changes
recorded here are in keeping with two phase structural
rearrangements previously observed for immunoglobins
exposed to low pH,47,48 with onset of unfolding occurring
below pH 6 and severe distortion of structure evident below
pH 3.
■ CONCLUSION
CD and ﬂuorescence spectroscopy provide valuable insights
into the intricate unfolding events of proteins. The automation
of a system that integrates an automated loading robot and
low-volume capillary ﬂow cell with these orthogonal
spectroscopic techniques has been described and evaluated
with respect to (i) loading method, (ii) data quality, and (iii)
sample requirements. We found that air-segmented delivery of
samples was the best loading method, and the use of a ﬁxed-
position quartz capillary ﬂow cell aﬀorded consistently high-
quality spectra. Further, we showed that reproducible and high
transfer eﬃciency loading could be achieved using sample
volumes as low as 40 μL. Thus, this system provides a number
of beneﬁts that include eliminating manual sample loading and
cleaning procedures, reducing sample requirements by up to 5-
fold, and increasing productive machine time for prolonged,
unattended running periods. In an industrial or research
setting, these advantages could translate into important time
and cost savings.
The presented case studies demonstrated the utility of ht-
caCD/F for rapidly evaluating the distinct unfolding patterns
of secondary and tertiary elements of protein, delivering
precisely the results expected had CD and ﬂuorescence
measurement been conducted in conventional manner.
Under increasing concentrations of urea, unfolding of BSA
was seen to occur at >2 M via an intermediate state at 5 M
urea, whereas mAb retained it structure up to >6 M urea. It is
noteworthy that operation of the ht-caCD/F system was
unperturbed by the high viscosity of concentrated (8 M) urea
solutions. In a process development application, unfolding of
an IgG1 in various low-pH buﬀers was shown to occur via a
two-stage unfolding sequence, with partial unfolding occurring
between pH 6 and 3 and severe unfolding below pH 3. Quickly
gathering such information can be invaluable for informing the
choice of appropriate processing or formulation conditions to
reduce the risk of costly downstream failure. In an industrial
biomanufacturing setting, we envisage further adaption of the
described system to collect structural data from proteins as
they elute oﬀ chromatography columns. While chiral detection
of optically active compounds in HPLC systems has hitherto
proven useful for the detection of biologically signiﬁcant small
molecules,20,21 the combination of new, sensitive CD and
ﬂuorescence detectors with capillary ﬂow paths presents a
promising opportunity to monitor conformational changes of
eluted proteins and overcome the sensitivity issues reported in
previous endeavors.49
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